ACAD
ACADIA Pharmaceuticals Inc.
21.09
USD
This page is just a preview of the data found in TrendSpider’s full version
ACADIA Pharmaceuticals Inc. stock is down -5% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45% of the previous 19 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 28 Nov 15:09 | 19 Jan, 2024 | 20.00 | 942 | ||
| 28 Nov 18:42 | 19 Jan, 2024 | 22.00 | 2152 | ||
| 28 Nov 19:27 | 19 Jan, 2024 | 21.00 | 6 | ||
| 30 Nov 17:26 | 15 Mar, 2024 | 24.00 | 86 | ||
| 30 Nov 19:45 | 19 Jan, 2024 | 25.00 | 3373 | ||
| 07 Dec 14:58 | 15 Dec, 2023 | 21.00 | 1540 | ||
| 08 Dec 17:30 | 15 Dec, 2023 | 22.00 | 5606 | ||
| 08 Dec 17:31 | 15 Dec, 2023 | 22.00 | 5606 | ||
| 08 Dec 17:32 | 15 Dec, 2023 | 22.00 | 5606 | ||
| 11 Dec 20:29 | 15 Dec, 2023 | 22.00 | 7105 |
ACADIA Pharmaceuticals Inc. focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
